By Y. Peter Kang ( February 2, 2016, 4:38 PM EST) -- Ahead of an upcoming jury trial, a California federal judge on Tuesday declined a request by Gilead Sciences to invalidate two patents held by rival Merck that were purportedly infringed by Gilead's hepatitis C drugs, finding that Merck presented enough evidence showing its patents were useful....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.